177 related articles for article (PubMed ID: 31166085)
1. Three Discipline Collaborative Radiation Therapy (3DCRT) Special Debate: I would treat prostate cancer with proton therapy.
Carrier F; Liao Y; Mendenhall N; Guerrieri P; Todor D; Ahmad A; Dominello M; Joiner MC; Burmeister J
J Appl Clin Med Phys; 2019 Jul; 20(7):7-14. PubMed ID: 31166085
[No Abstract] [Full Text] [Related]
2. Three discipline collaborative radiation therapy (3DCRT) special debate: I would treat all early-stage NSCLC patients with SBRT.
Mohindra P; Sawant A; Griffin RJ; Lamichhane N; Vlashi E; Xu-Welliver M; Dominello M; Joiner MC; Burmeister J
J Appl Clin Med Phys; 2019 Mar; 20(3):7-13. PubMed ID: 30793828
[No Abstract] [Full Text] [Related]
3. Three discipline collaborative radiation therapy (3DCRT) special debate: The United States should build additional proton therapy facilities.
Braunstein S; Wang L; Newhauser W; Tenenholz T; Rong Y; van der Kogel A; Dominello M; Joiner MC; Burmeister J
J Appl Clin Med Phys; 2019 Feb; 20(2):7-12. PubMed ID: 30735613
[No Abstract] [Full Text] [Related]
4. Comparison of rectal dose reduction by a hydrogel spacer among 3D conformal radiotherapy, volumetric-modulated arc therapy, helical tomotherapy, CyberKnife and proton therapy.
Saito M; Suzuki T; Sugama Y; Marino K; Sano N; Komiyama T; Aoki S; Maehata Y; Yoshizawa K; Ashizawa K; Suzuki H; Ueda K; Miyasaka Y; Araya M; Takahashi H; Onishi H
J Radiat Res; 2020 May; 61(3):487-493. PubMed ID: 32211861
[TBL] [Abstract][Full Text] [Related]
5. A snapshot of medical physics practice patterns.
Kisling KD; Ger RB; Netherton TJ; Cardenas CE; Owens CA; Anderson BM; Lee J; Rhee DJ; Edward SS; Gay SS; He Y; David SD; Yang J; Nitsch PL; Balter PA; Urbauer DL; Peterson CB; Court LE; Dube S
J Appl Clin Med Phys; 2018 Nov; 19(6):306-315. PubMed ID: 30272385
[TBL] [Abstract][Full Text] [Related]
6. Robust optimization to reduce the impact of biological effect variation from physical uncertainties in intensity-modulated proton therapy.
Bai X; Lim G; Grosshans D; Mohan R; Cao W
Phys Med Biol; 2019 Jan; 64(2):025004. PubMed ID: 30523932
[TBL] [Abstract][Full Text] [Related]
7. Quality assurance evaluation of spot scanning beam proton therapy with an anthropomorphic prostate phantom.
Iqbal K; Gillin M; Summers PA; Dhanesar S; Gifford KA; Buzdar SA
Br J Radiol; 2013 Nov; 86(1031):20130390. PubMed ID: 24049129
[TBL] [Abstract][Full Text] [Related]
8. Practice patterns and recommendations for pediatric image-guided radiotherapy: A Children's Oncology Group report.
Hua CH; Vern-Gross TZ; Hess CB; Olch AJ; Alaei P; Sathiaseelan V; Deng J; Ulin K; Laurie F; Gopalakrishnan M; Esiashvili N; Wolden SL; Krasin MJ; Merchant TE; Donaldson SS; FitzGerald TJ; Constine LS; Hodgson DC; Haas-Kogan DA; Mahajan A; Laack NN; Marcus KJ; Taylor PA; Ahern VA; Followill DS; Buchsbaum JC; Breneman JC; Kalapurakal JA
Pediatr Blood Cancer; 2020 Oct; 67(10):e28629. PubMed ID: 32776500
[TBL] [Abstract][Full Text] [Related]
9. Have we reached proton beam therapy dosimetric limitations? - A novel robust, delivery-efficient and continuous spot-scanning proton arc (SPArc) therapy is to improve the dosimetric outcome in treating prostate cancer.
Ding X; Li X; Qin A; Zhou J; Yan D; Stevens C; Krauss D; Kabolizdeh P
Acta Oncol; 2018 Mar; 57(3):435-437. PubMed ID: 28774218
[No Abstract] [Full Text] [Related]
10. Consensus and differences in primary radiotherapy for localized and locally advanced prostate cancer in Switzerland: A survey on patterns of practice.
Panje CM; Dal Pra A; Zilli T; R Zwahlen D; Papachristofilou A; Herrera FG; Matzinger O; Plasswilm L; Putora PM
Strahlenther Onkol; 2015 Oct; 191(10):778-86. PubMed ID: 25986251
[TBL] [Abstract][Full Text] [Related]
11. A fast robust optimizer for intensity modulated proton therapy using GPU.
Xu Y; Chen J; Cao R; Liu H; Xu XG; Pei X
J Appl Clin Med Phys; 2020 Mar; 21(3):123-133. PubMed ID: 32141699
[TBL] [Abstract][Full Text] [Related]
12. Point/Counterpoint. Proton therapy is the best radiation treatment modality for prostate cancer.
Moyers MF; Pouliot J; Orton CG
Med Phys; 2007 Feb; 34(2):375-8. PubMed ID: 17388153
[No Abstract] [Full Text] [Related]
13. Prostate bed irradiation with alternative radio-oncological approaches (PAROS) - a prospective, multicenter and randomized phase III trial.
Koerber SA; Katayama S; Sander A; Jaekel C; Haefner MF; Debus J; Herfarth K
Radiat Oncol; 2019 Jul; 14(1):122. PubMed ID: 31291969
[TBL] [Abstract][Full Text] [Related]
14. Shortening delivery times of intensity modulated proton therapy by reducing proton energy layers during treatment plan optimization.
van de Water S; Kooy HM; Heijmen BJ; Hoogeman MS
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):460-8. PubMed ID: 25823447
[TBL] [Abstract][Full Text] [Related]
15. Practice patterns of palliative radiation therapy in pediatric oncology patients in an international pediatric research consortium.
Rao AD; Chen Q; Ermoian RP; Alcorn SR; Figueiredo MLS; Chen MJ; Dieckmann K; MacDonald SM; Ladra MM; Kobyzeva D; Nechesnyuk AV; Nilsson K; Ford EC; Winey BA; Villar RC; Terezakis SA
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28696044
[TBL] [Abstract][Full Text] [Related]
16. Proton versus photon-based radiation therapy for prostate cancer: emerging evidence and considerations in the era of value-based cancer care.
Kamran SC; Light JO; Efstathiou JA
Prostate Cancer Prostatic Dis; 2019 Dec; 22(4):509-521. PubMed ID: 30967625
[TBL] [Abstract][Full Text] [Related]
17. Passive proton therapy vs. IMRT planning study with focal boost for prostate cancer.
Yeo I; Nookala P; Gordon I; Schulte R; Barnes S; Ghebremedhin A; Wang N; Yang G; Ling T; Bush D; Slater J; Patyal B
Radiat Oncol; 2015 Oct; 10():213. PubMed ID: 26499318
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric study of uniform scanning proton therapy planning for prostate cancer patients with a metal hip prosthesis, and comparison with volumetric-modulated arc therapy.
Rana S; Cheng C; Zheng Y; Hsi W; Zeidan O; Schreuder N; Vargas C; Larson G
J Appl Clin Med Phys; 2014 May; 15(3):4611. PubMed ID: 24892333
[TBL] [Abstract][Full Text] [Related]
19. Comparison of linear and nonlinear programming approaches for "worst case dose" and "minmax" robust optimization of intensity-modulated proton therapy dose distributions.
Zaghian M; Cao W; Liu W; Kardar L; Randeniya S; Mohan R; Lim G
J Appl Clin Med Phys; 2017 Mar; 18(2):15-25. PubMed ID: 28300378
[TBL] [Abstract][Full Text] [Related]
20. Towards real-time PGS range monitoring in proton therapy of prostate cancer.
Magalhaes Martins P; Freitas H; Tessonnier T; Ackermann B; Brons S; Seco J
Sci Rep; 2021 Jul; 11(1):15331. PubMed ID: 34321492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
